Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis

Authors


Correspondence
Cihan Yurdaydin, MD, University of Ankara Medical School, Department of Gastroenterology, Cebeci Tip Fakültesi Hastanesi, Dikimevi, 06100 Ankara, Turkey
Tel: +90 312 319 4908
Fax: +90 312 363 6213
e-mail: cihan.yurdaydin@medicine.ankara.edu.tr

Abstract

Background: Recent reports suggest a decline of delta hepatitis (DH) in the West as well as in the Far East.

Aim: To study the DH seroepidemiology in Turkey.

Methods: Statistical power analysis was utilized based on data available in a recent article using prevalence figure estimates. Binominal distribution was applied in order to assess the number of samples required to estimate the prevalence with a given precision.

Results: Out of 62 studies in the original study, 32 were eliminated because of insufficient power. A total of 6734 patients (5231 with chronic hepatitis and 1503 with cirrhosis) were analysed. Anti-HDV seropositivity among patients with chronic hepatitis B (CHB) and hepatitis B-induced cirrhosis was lowest in the west of the country and highest in the southeast (5 vs. 27%, P<0.0001 and 20 vs. 46%, P<0.0001) respectively. Compared with data obtained before 1995, after 1995, DH prevalence in patients with CHB and cirrhosis decreased from 29 to 12% (P<0.0001) and from 38 to 27% (P=0.03) in central and southeast Turkey and from 38 to 20% (P<0.0001) and from 66 to 46% (P<0.002) in west and southeast Turkey respectively.

Conclusion: Despite the decrease of its prevalence in Turkey, DH remains a significant health problem in parts of the country with low socio-economic level.

Ancillary